Europe Orphan Drug Pipeline Analysis 2014
Reportstack, provider of premium market research reports announces the addition of Europe Orphan Drug Pipeline Analysis 2014 market report to its offering
Rare diseases are classified as those that affect fewer than 200,000 in the United States and less than 5 in 10,000 in the EU. The term orphan was associated with these drugs in order to reflect the lack of interest by pharma companies. In the European Union, orphan drugs are known as orphan medicinal products. Many treatments which...
View full press release